Cargando…

Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review

INTRODUCTION: Bleeding is the most frequent complication in patients receiving venoarterial or venovenous extracorporeal membrane oxygenation (ECMO). Recombinant activated factor VII (rFVIIa) has been used in these patients with conflicting results. We describe our experience with rFVIIa for refract...

Descripción completa

Detalles Bibliográficos
Autores principales:	Repessé, Xavier, Au, Siu Ming, Bréchot, Nicolas, Trouillet, Jean-Louis, Leprince, Pascal, Chastre, Jean, Combes, Alain, Luyt, Charles-Edouard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057417/ https://www.ncbi.nlm.nih.gov/pubmed/23531278 http://dx.doi.org/10.1186/cc12581

Ejemplares similares

The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome
por: Schmidt, Matthieu, et al.
Publicado: (2013)

Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation
por: Corsi, Fillipo, et al.
Publicado: (2017)

Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock
por: Hekimian, Guillaume, et al.
Publicado: (2016)

Antibiotic stewardship in the intensive care unit
por: Luyt, Charles-Edouard, et al.
Publicado: (2014)

Virus-induced acute respiratory distress syndrome: Epidemiology, management and outcome
por: Luyt, Charles-Édouard, et al.
Publicado: (2011)

Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding
por: Conen, Anna, et al.
Publicado: (2007)

Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France
por: Levy, David, et al.
Publicado: (2021)

Ischemic and hemorrhagic brain injury during venoarterial-extracorporeal membrane oxygenation
por: Le Guennec, Loïc, et al.
Publicado: (2018)

Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation
por: Touchard, Cyril, et al.
Publicado: (2018)

Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia
por: Tang, Yaqiong, et al.
Publicado: (2015)

Spinal cord infarction during venoarterial-extracorporeal membrane oxygenation support
por: Le Guennec, Loïc, et al.
Publicado: (2020)

359. Ventilator-associated pneumonia in patients with SARS-CoV-2–associated acute respiratory failure requiring mechanical ventilation: a retrospective cohort study
por: Luyt, Charles-Edouard, et al.
Publicado: (2020)

Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation
por: Bay, Pierre, et al.
Publicado: (2021)

Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
por: Schmidt, Matthieu, et al.
Publicado: (2021)

Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
por: Puetz, John
Publicado: (2010)

Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood
por: Lemaitre, Florian, et al.
Publicado: (2015)

The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
por: Lin, Y, et al.
Publicado: (2012)

Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope
por: Qi, Xingshun, et al.
Publicado: (2017)

Factor VIIa for severe cardiac surgical bleeding
por: Diprose, P, et al.
Publicado: (2002)

Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shock
por: Montero, Santiago, et al.
Publicado: (2022)

The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
por: Meeks, Shannon L., et al.
Publicado: (2019)

Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005)

Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation
por: Aissi James, Sarah, et al.
Publicado: (2022)

Severe pulmonary embolism in COVID-19 patients: a call for increased awareness
por: Hékimian, Guillaume, et al.
Publicado: (2020)

Single-center experience with pediatric patients on ECMO who received recombinant factor VIIa for refractory bleeding
por: Alsohime, Fahad, et al.
Publicado: (2017)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

Extracorporeal Membrane Oxygenation instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19–associated Acute Respiratory Distress Syndrome
por: Schmidt, Matthieu, et al.
Publicado: (2021)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008)

Recombinant factor VIIa in severe trauma: further study needed
por: Galvan, Dan A, et al.
Publicado: (2006)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation
por: Lemaitre, Florian, et al.
Publicado: (2010)

Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational study
por: Luyt, Charles-Edouard, et al.
Publicado: (2020)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6neioel67k1megje4h2aao5dkt